R(+)-Methanandamide Induces Cyclooxygenase-2 Expression in Human Neuroglioma Cells via a Non-cannabinoid Receptor-Mediated Mechanism
- 7 September 2001
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 286 (5), 1144-1152
- https://doi.org/10.1006/bbrc.2001.5518
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Cannabis and cannabinoids: pharmacology and rationale for clinical use.Complementary Medicine Research, 1999
- Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte SubpopulationsEuropean Journal of Biochemistry, 1995
- Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptorsBiochemical Pharmacology, 1995
- Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanismBiochemical Pharmacology, 1994
- Molecular characterization of a peripheral receptor for cannabinoidsNature, 1993
- Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction.Proceedings of the National Academy of Sciences, 1993
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- Structure of a cannabinoid receptor and functional expression of the cloned cDNANature, 1990
- Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapyInvestigational New Drugs, 1988
- A Total Synthesis of dl-Δ1-Tetrahydrocannabinol, the Active Constituent of Hashish1Journal of the American Chemical Society, 1965